Prevalence of dyslipidaemia and associated risk factors among Balearic Islands adolescents, a Mediterranean region.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 25351644)

Published in Eur J Clin Nutr on October 29, 2014

Authors

M M Bibiloni1, R Salas2, A Pons1, J A Tur1

Author Affiliations

1: Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, IdISPa, and CIBERobn (Physiopathology of Obesity and Nutrition CB12/03/30038), Palma de Mallorca, Spain.
2: Faculty of Public Health Nutrition, Autonomous University of Nuevo León, Monterrey, Mexico.

Articles cited by this

Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ (2000) 56.80

Evidence based physical activity for school-age youth. J Pediatr (2005) 13.50

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52

Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics (2011) 7.30

Skinfold equations for estimation of body fatness in children and youth. Hum Biol (1988) 6.65

Lipid screening and cardiovascular health in childhood. Pediatrics (2008) 6.62

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med (1988) 5.94

Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics (2012) 3.98

A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message--'keep your waist circumference to less than half your height'. Int J Obes (Lond) (2006) 3.65

Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11

Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol (1991) 2.52

Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA (2012) 2.04

Body fat measurement in adolescents: comparison of skinfold thickness equations with dual-energy X-ray absorptiometry. Eur J Clin Nutr (2005) 1.52

Immunity, atherosclerosis and cardiovascular disease. BMC Med (2013) 1.49

Waist measurement correlates to a potentially atherogenic lipoprotein profile in obese 12-14-year-old children. Acta Paediatr (1994) 1.46

Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study. Pediatrics (2006) 1.41

Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study. Eur J Epidemiol (2001) 1.24

Tracking of physical and physiological risk variables among ethnic subgroups from third to eighth grade: the Child and Adolescent Trial for Cardiovascular Health cohort study. Prev Med (2002) 1.22

Tracking of serum HDL-cholesterol and other lipids in children and adolescents: the Cardiovascular Risk in Young Finns Study. Prev Med (1991) 1.20

Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation (2009) 1.16

Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study. Am J Epidemiol (1994) 1.13

Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS One (2012) 1.07

[Prevalence of physical inactivity and associated factors in adolescents]. Rev Assoc Med Bras (2009) 0.97

Prevalence and risk factors for obesity in Balearic Islands adolescents. Br J Nutr (2009) 0.95

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr (2010) 0.94

Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents. Metabolism (2007) 0.94

Metabolic syndrome in adolescents in the Balearic Islands, a Mediterranean region. Nutr Metab Cardiovasc Dis (2010) 0.89

Challenges of existing pediatric dyslipidemia guidelines: call for reappraisal. Circulation (2008) 0.86

[Validity of body mass index and fat mass index as indicators of overweight status in Spanish adolescents: Esccola Study]. Med Clin (Barc) (2010) 0.85

The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys. BMC Med Res Methodol (2011) 0.84

A review of guidelines for dyslipidemia in children and adolescents. WMJ (2012) 0.84

Direct measurement of low-density-lipoprotein cholesterol is more effective than total cholesterol for the purpose of lipoprotein screening. Prev Med (2001) 0.83

Prevalence of pediatric dyslipidemia: comparison of a population-based claims database to national surveys. Pharmacoepidemiol Drug Saf (2010) 0.83

A perspective on obesity. Am J Med Sci (1995) 0.83

Association between sedentary behaviour and socioeconomic factors, diet and lifestyle among the Balearic Islands adolescents. BMC Public Health (2012) 0.83

Evaluation of serum lipid levels in children. Pediatr Cardiol (2012) 0.83

LDL-cholesterol and body mass index among Japanese schoolchildren: a population-based cross-sectional study. Lipids Health Dis (2013) 0.82

Cholesterol screening and management in children and young adults should start early--NO! Clin Cardiol (2012) 0.79

Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents. Paediatr Drugs (2013) 0.78